Zhou et al. reported [18] that the incidence of CIN was 7.9% under the continuous administration of ACE inhibitors (control: 8.2%, RR 0.95, and 95% CI 0.57–1.58). The gene discussed is ACE; the disease is cervical squamous intraepithelial neoplasia.